AKT1 and breast cancer: The nuclear lncRNA Linc00839 is upregulated in chemoresistant breast cancer cells, and its overexpression enhances Myc and activates the PI3K/AKT signaling pathway, thus facilitating proliferation, invasion, and migration, as well as leading to a poor prognosis in breast cancer (Chen et al., 2020).